External Validation of the Colon Life Nomogram for Predicting 12-Week Mortality in Dutch Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil in Daily Practice

Autor: Patricia A. H. Hamers, G. Emerens Wensink, Maarten van Smeden, Geraldine R. Vink, Lidwien P. Smabers, Renee A. Lunenberg, Miangela M. Laclé, Miriam Koopman, Anne M. May, Jeanine M. L. Roodhart

Publikováno v: Cancers; Volume 14; Issue 20; Pages: 5094

Background: Predicting prognosis in refractory metastatic colorectal cancer (mCRC) patients is needed to guide decision making. The Colon Life nomogram was developed to predict 12-week mortality in refractory mCRC patients. The aim of this study is t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd71f76d368e2c5a207248da611eb04b

Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era

Autor: Gerrit Jan Veldhuis, Edith B. van Druten, Cathrien S. Tromp-van Driel, Ronald C. Rietbroek, Gerty J. de Klerk, Annebeth W. Haringhuizen, Theo van Voorthuizen, J. E. Vincent, Manuel L. R. Tjin-A-Ton, Anne M. May, Ankie M.T. van der Velden, Geraldine R. Vink, Brigitte C. M. Haberkorn, J. Cornelis B. Hunting, Joyce M. van Dodewaard-de Jong, R. Hoekstra, Lieke H.J. Simkens, Sandra D. Bakker, Patricia Quarles van Ufford-Mannesse, Jeanine M.L. Roodhart, Geert-Jan Creemers, Marjan A. van Dijk, Marco B. Polee, G. Emerens Wensink, Cornelis J. A. Punt, Daan ten Bokkel Huinink, Marloes A. G. Elferink, Bea Tanis, Franchette W P J van den Berkmortel, Henk M.W. Verheul, Danielle Mathijssen-van Stein, Miriam Koopman, Hanneke J. H. M. J. Vestjens, Sandra A Radema, J.F.M. Pruijt, Monique M. Troost, Onno Kranenburg, Jan Willem B. de Groot, Anke J. M. van der Pas, Agnes J. van de Wouw, Emile D. Kerver, Patricia A. H. Hamers, Linda Mol

Publikováno v: British Journal of Cancer, 124(2), 399-406. Nature Publishing Group
British Journal of Cancer
British Journal of Cancer, 124, 399-406
British journal of cancer, 124(2), 399-406. Nature Publishing Group
British Journal of Cancer, 124, 2, pp. 399-406
Wensink, G E, Elferink, M A G, May, A M, Mol, L, Hamers, P A H, Bakker, S D, Creemers, G-J, de Groot, J W B, de Klerk, G J, Haberkorn, B C M, Haringhuizen, A W, Hoekstra, R, Hunting, J C B, Kerver, E D, Mathijssen-van Stein, D, Polée, M B, Pruijt, J F M, Quarles van Ufford-Mannesse, P, Radema, S, Rietbroek, R C, Simkens, L H J, Tanis, B C, ten Bokkel Huinink, D, Tjin-A-Ton, M L R, Tromp-van Driel, C S, Troost, M M, van de Wouw, A J, van den Berkmortel, F W P J, van der Pas, A J M, van der Velden, A M T, van Dijk, M A, van Dodewaard-de Jong, J M, van Druten, E B, van Voorthuizen, T, Jan Veldhuis, G, Verheul, H M W, Vestjens, H J H M J, Vincent, J, Kranenburg, O W, Punt, C J A, Vink, G R, Roodhart, J M L & Koopman, M 2021, ' Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era ', British Journal of Cancer, vol. 124, no. 2, pp. 399-406 . https://doi.org/10.1038/s41416-020-01076-0

BackgroundMetastatic colorectal cancer patients with deficient mismatch repair (dMMR mCRC) benefit from immunotherapy. Interpretation of the single-arm immunotherapy trials is complicated by insignificant survival data during systemic non-immunothera

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0117d001dca85f91775734a7c4208f2d
https://research.vumc.nl/en/publications/4d0a604d-b0c0-44c7-b106-5b8d5ff6f3c4

Informing metastatic colorectal cancer patients by quantifying multiple scenarios for survival based on real-life data

Autor: Geraldine R. Vink, Marloes A. G. Elferink, Patricia A. H. Hamers, Miriam Koopman, Cornelis J. A. Punt, Anne Maria May, Rebecca K. Stellato

Publikováno v: Journal of Clinical Oncology. 38:32-32

32 Background: Reported median overall survival (mOS) in trials of metastatic colorectal cancer (mCRC) patients receiving systemic therapy has increased to over 30 months. When informing patients, many clinicians quote the mOS reported in these trial

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cec19e321149dfaa0f13d3a40044d3cc
https://doi.org/10.1200/jco.2020.38.4_suppl.32

An ICU patient with spots and a peculiar pneumonia

Autor: Steven F T Thijsen, Lenneke E M Haas, René van der Griend, Patricia A H Hamers

Publikováno v: Case Reports. 2013:bcr2013008693-bcr2013008693

This is the first report of varicella zoster virus (VZV) pneumonia in an adult patient treated with rituximab because of autoimmune haemolytic anaemia and it illustrates that a VZV infection should be considered when an immunocompromised patient deve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1becfe8a794e3f3d4b1cde1b6bc12e4
https://doi.org/10.1136/bcr-2013-008693